These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20386731)

  • 1. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.
    Skowronski DM; De Serres G; Crowcroft NS; Janjua NZ; Boulianne N; Hottes TS; Rosella LC; Dickinson JA; Gilca R; Sethi P; Ouhoummane N; Willison DJ; Rouleau I; Petric M; Fonseca K; Drews SJ; Rebbapragada A; Charest H; Hamelin ME; Boivin G; Gardy JL; Li Y; Kwindt TL; Patrick DM; Brunham RC;
    PLoS Med; 2010 Apr; 7(4):e1000258. PubMed ID: 20386731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal influenza vaccine and increased risk of pandemic A/H1N1‐related illness: first detection of the association in British Columbia, Canada.
    Janjua NZ; Skowronski DM; Hottes TS; Osei W; Adams E; Petric M; Sabaiduc S; Chan T; Mak A; Lem M; Tang P; Patrick DM; De Serres G; Bowering D
    Clin Infect Dis; 2010 Nov; 51(9):1017-27. PubMed ID: 20887210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.
    Skowronski DM; Janjua NZ; De Serres G; Hottes TS; Dickinson JA; Crowcroft N; Kwindt TL; Tang P; Charest H; Fonseca K; Gubbay JB; Bastien N; Li Y; Petric M
    BMJ; 2011 Feb; 342():c7297. PubMed ID: 21292718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.
    Johns MC; Eick AA; Blazes DL; Lee SE; Perdue CL; Lipnick R; Vest KG; Russell KL; DeFraites RF; Sanchez JL
    PLoS One; 2010 May; 5(5):e10722. PubMed ID: 20502705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.
    Valenciano M; Kissling E; Cohen JM; Oroszi B; Barret AS; Rizzo C; Nunes B; Pitigoi D; Larrauri Cámara A; Mosnier A; Horvath JK; O'Donnell J; Bella A; Guiomar R; Lupulescu E; Savulescu C; Ciancio BC; Kramarz P; Moren A
    PLoS Med; 2011 Jan; 8(1):e1000388. PubMed ID: 21379316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada.
    Gilca R; De Serres G; Boulianne N; Ouhoummane N; Papenburg J; Douville-Fradet M; Fortin É; Dionne M; Boivin G; Skowronski DM
    Influenza Other Respir Viruses; 2011 Jul; 5(4):247-55. PubMed ID: 21651735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.
    Hellenbrand W; Jorgensen P; Schweiger B; Falkenhorst G; Nachtnebel M; Greutélaers B; Traeder C; Wichmann O
    BMC Infect Dis; 2012 May; 12():127. PubMed ID: 22650369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
    Soonawala D; Rimmelzwaan GF; Gelinck LB; Visser LG; Kroon FP
    PLoS One; 2011 Jan; 6(1):e16496. PubMed ID: 21304982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk.
    Skowronski DM; Hamelin ME; De Serres G; Janjua NZ; Li G; Sabaiduc S; Bouhy X; Couture C; Leung A; Kobasa D; Embury-Hyatt C; de Bruin E; Balshaw R; Lavigne S; Petric M; Koopmans M; Boivin G
    PLoS One; 2014; 9(1):e86555. PubMed ID: 24475142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.
    Faix DJ; Hawksworth AW; Myers CA; Hansen CJ; Ortiguerra RG; Halpin R; Wentworth D; Pacha LA; Schwartz EG; Garcia SM; Eick-Cost AA; Clagett CD; Khurana S; Golding H; Blair PJ
    PLoS One; 2012; 7(4):e34581. PubMed ID: 22514639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.
    Yin JK; Chow MY; Khandaker G; King C; Richmond P; Heron L; Booy R
    Vaccine; 2012 May; 30(21):3209-22. PubMed ID: 22387221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High effectiveness of pandemic influenza A (H1N1) vaccination in healthcare workers from a Portuguese hospital.
    Costa JT; Silva R; Tavares M; Nienhaus A
    Int Arch Occup Environ Health; 2012 Oct; 85(7):747-52. PubMed ID: 22045387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus?
    Viboud C; Simonsen L
    PLoS Med; 2010 Apr; 7(4):e1000259. PubMed ID: 20386730
    [No Abstract]   [Full Text] [Related]  

  • 15. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approach.
    Eick-Cost AA; Tastad KJ; Guerrero AC; Johns MC; Lee SE; Macintosh VH; Burke RL; Blazes DL; Russell KL; Sanchez JL
    PLoS One; 2012; 7(7):e41435. PubMed ID: 22859985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine.
    Rosella LC; Groenwold RH; Crowcroft NS
    Vaccine; 2011 Nov; 29(49):9194-200. PubMed ID: 22001885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.
    Savulescu C; Jiménez-Jorge S; de Mateo S; Pozo F; Casas I; Breña PP; Galmés A; Vanrell JM; Rodriguez C; Vega T; Martinez A; Torner N; Ramos JM; Serrano MC; Castilla J; Cenoz MG; Altzibar JM; Arteagoitia JM; Quiñones C; Perucha M; Larrauri A
    BMC Public Health; 2011 Nov; 11():899. PubMed ID: 22129083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonal Influenza Vaccine Impact on Pandemic H1N1 Vaccine Efficacy.
    Lee RU; Phillips CJ; Faix DJ
    Clin Infect Dis; 2019 May; 68(11):1839-1846. PubMed ID: 30239636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.